Introdução
O que você precisa saber de cara
Uma doença renal genética que causa a perda progressiva da função dos rins, provocada por mutações (alterações) nos genes que produzem as proteínas uromodulina (UMOD), fator nuclear de hepatócitos-1β (HNF1B), renina (REN) ou mucina-1 (MUC1).
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 9 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 41 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
2 genes identificados com associação a esta condição.
The alpha subunit has cell adhesive properties. Can act both as an adhesion and an anti-adhesion protein. May provide a protective layer on epithelial cells against bacterial and enzyme attack The beta subunit contains a C-terminal domain which is involved in cell signaling, through phosphorylations and protein-protein interactions. Modulates signaling in ERK, SRC and NF-kappa-B pathways. In activated T-cells, influences directly or indirectly the Ras/MAPK pathway. Promotes tumor progression. Re
Apical cell membraneSecretedCell membraneCytoplasmNucleus
Functions in biogenesis and organization of the apical membrane of epithelial cells of the thick ascending limb of Henle's loop (TALH), where it promotes formation of complex filamentous gel-like structure that may play a role in the water barrier permeability (Probable). May serve as a receptor for binding and endocytosis of cytokines (IL-1, IL-2) and TNF (PubMed:3498215). Facilitates neutrophil migration across renal epithelia (PubMed:20798515) In the urine, may contribute to colloid osmotic p
Apical cell membraneBasolateral cell membraneCell projection, cilium membraneSecreted
Tubulointerstitial kidney disease, autosomal dominant 1
A form of autosomal dominant tubulointerstitial kidney disease, a genetically heterogeneous disorder characterized by slowly progressive loss of kidney function, bland urinary sediment, hyperuricemia, absent or mildly increased albuminuria, lack of severe hypertension during the early stages, and normal or small kidneys on ultrasound. Renal histology shows variable abnormalities including interstitial fibrosis with tubular atrophy, microcystic dilatation of the tubules, thickening of tubular basement membranes, medullary cysts, and secondary glomerulosclerotic or glomerulocystic changes with abnormal glomerular tufting. There is significant variability, as well as incomplete penetrance.
Medicamentos aprovados (FDA)
1 medicamento encontrado nos registros da FDA americana.
Variantes genéticas (ClinVar)
206 variantes patogênicas registradas no ClinVar.
Vias biológicas (Reactome)
10 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Doença renal túbulo-intersticial autossômica dominante
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Pesquisa e ensaios clínicos
Nenhum ensaio clínico registrado para esta condição.
Publicações mais relevantes
Mutations in UMOD Contribute to the Pathogenesis of ADTKD-UMOD by Influencing the Function of Complement Factor H.
Tubular atrophy and interstitial fibrosis are basic renal pathological changes in autosomal dominant tubulointerstitial kidney disease (ADTKD). Reduced secretion or abnormal structure of uromodulin (UMOD) are recognised pathogenic factors of ADTKD. Studies show uromodulin binds complement factor H (cFH), enhancing its ability to inhibit complement activation. Overactivation of the complement system contributes to tubulointerstitial injury. Therefore, exploring the UMOD-tubulointerstitial fibrosis link may aid in the development of treatment for ADTKD-UMOD. Immunofluorescence staining detected complement deposition in patients' kidneys. Uromodulin's binding affinity for cFH was assessed using microthermophoresis. The effect of this binding on cFH function was analysed using C3b degradation and erythrocyte hemolysis tests. Recombinant wild-type and mutant uromodulin proteins were expressed and tested using the aforementioned methods. Complement factor B was detected in the kidneys of patients with ADTKD-UMOD. Patient-derived uromodulin showed reduced binding to cFH and decreased capacity to assist in C3b cleavage and hemolysis inhibition. Recombinant wild-type uromodulin significantly enhanced C3b cleavage (p < 0.001) and inhibited hemolysis (p < 0.01). Uromodulin mutants showed reduced binding to cFH and limited ability to promote C3b degradation, with no significant hemolysis inhibition. Impaired interactions between mutants and cFH may lead to insufficient inhibition of complement activity, triggering tubulointerstitial fibrosis.
MANF Clears Mutant Uromodulin in Human Kidney Organoids of Autosomal Dominant Tubulointerstitial Kidney Disease.
Autosomal dominant tubulointerstitial kidney disease due to uromodulin mutations (ADTKD-UMOD) is one of the leading hereditary kidney diseases. Currently there is no targeted treatment. To illuminate human relevance of mesencephalic astrocyte-derived neurotrophic factor (MANF)-based therapy, we have established patient induced pluripotent stem cell (iPSC)-derived kidney organoid model carrying UMOD p.H177-R185del, the leading mutation causing ADTKD. We have discovered that MANF can directly bind and repress ER calcium release channel IP3R1, thus enhancing AMPK-induced autophagy in a TRIB3-dependent manner. The therapeutic implication of this finding may well be extended to other protein misfolding diseases.
De novo SEC61A1 mutation in congenital anemia and early-onset kidney disease: Case report and review of the literature.
Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a rare genetic disorder characterized by tubular damage and interstitial fibrosis, with inescapable progression to end-stage renal disease. SEC61A1-related ADTKD has long been neglected and underrecognized because of its rarity, insidious onset and variable clinical manifestations. A 13-year-old boy was referred to the pediatric nephrology clinic due to renal insufficiency, which had been found unexpectedly while visiting the hospital because of growth retardation. He had normocytic normochromic anemia since early childhood and was recently found to have agranulocytosis. The evaluation suggested elevated serum creatinine, hyperuricemia, bland urinary sediment, the absence of proteinuria, and renal cysts. A novel de novo heterozygous missense variant in SEC61A1, Ser71Pro, was found. So far fifteen patients with SEC61A1-related ADTKD have been reported, most of whom presented with early-onset chronic kidney disease and hyperuricemia. The extrarenal features included growth retardation, hematological abnormalities, cognitive impairment, and immunological abnormalities. There is no specific treatment for the SEC61A1-related ADTKD. Most reported patients survived to adulthood with supportive treatment. This is the first case of SEC61A1-related ADTKD of Chinese origin, extending its phenotype and mutation spectrum. The diagnosis of SEC61A1-related ADTKD should be considered in patients with early-onset or familial chronic kidney disease, hematological abnormalities and growth retardation, and mutation analysis of SEC61A1 is needed.
A Partial UMOD Deletion Results in Altered Uromodulin Synthesis and Autosomal-Dominant Tubulointerstitial Kidney Disease-Uromodulin.
Autosomal dominant tubulointerstitial kidney disease-uromodulin (ADTKD-UMOD) is classically due to missense variants in UMOD that display a dominant-negative effect. Here, we describe a family with high clinical suspicion for ADTKD-UMOD for which no molecular diagnosis was obtained through standard techniques including extensive panel sequencing. Whole genome and long-read sequencing in multiple affected family members uncovered a large deletion (1,313 bp) encompassing part of exon 3, the entire intron 3 and exon 4, and part of intron 4, conserved regions of UMOD in which most known pathogenic variants are found. The pathogenic effect of the variant was validated through multimodal analysis of the urinary protein composition. Instead of loss of function, our data suggest that this deletion may result in an altered protein. This is the first large deletion demonstrated by functional assessment as responsible for ADTKD-UMOD, and importantly, it was undetected by conventional variant calling on short-read exome sequencing. Our results suggest that copy number variants may also be responsible for ADTKD-UMOD. We propose that when ADTKD is suspected but not explained by massive parallel sequencing and MUC1 analysis, additional sequencing techniques might unravel other types of genetic alteration, notably copy number variants, and thereby address unsolved ADTKD cases.
Plasma Metabolites Associated with CKD Stage in Autosomal Dominant Tubulointerstitial Kidney Disease.
This is the first large-scale metabolomic study in genetically confirmed autosomal dominant tubulointerstitial kidney disease (ADTKD), providing a new resource for rare kidney diseases. ADTKD-UMOD and ADTKD-MUC1 are metabolically indistinguishable across stages, supporting the development of unified monitoring strategies. The plasma kynurenine-to-tryptophan ratio increases with CKD progression, supporting its use as a noninvasive marker of inflammation in ADTKD. Metabolomic profiling has not yet been performed in autosomal dominant tubulointerstitial kidney disease (ADTKD) due to UMOD or MUC1 mutations and could provide valuable insights into the pathophysiology of these conditions and identify the biomarkers of disease activity. Untargeted metabolomic analysis of plasma samples was performed on a cohort comprising 40 controls, 51 individuals with ADTKD-UMOD, and 49 individuals with ADTKD-MUC1 with CKD stages ranging from 1 to 4. Principal component analysis and hierarchical clustering revealed that the metabolic profiles of controls and ADTKD-UMOD and ADTKD-MUC1 patients with CKD stages 1 and 2 were similar. The metabolome was also similar between patients with ADTKD-UMOD and ADTKD-MUC1 at each stage of CKD. Compared with stage 2 CKD, stage 3 CKD was characterized by an increased kynurenine-to-tryptophan ratio, indicating activation of indoleamine 2,3-dioxygenase, an inflammation-induced and rate-limiting enzyme of tryptophan metabolism, and increased levels of pseudouridine, 3-indoxylsulfate, N-formylmethione, N-acetylated amino acids, acylcarnitines, and several other metabolites. In total, 121 metabolites were identified as significantly altered in patients in stage 4 compared with controls. Enrichment analysis of this set revealed that the most significant alterations were in the biosynthesis of arginine and branched-chain amino acids, carnitine synthesis, transfer RNA metabolism, tryptophan catabolism, urea cycle, metabolism of amino acids, glucose homeostasis, and solute carrier-mediated transmembrane transport. Patients with ADTKD-UMOD and ADTKD-MUC1 had similar metabolomic profiles across CKD stages. Although ADTKD is a tubulointerstitial kidney disease rather than glomerular, the effects on the metabolomic pathways appear comparable with those of other forms of CKD. The kynurenine-to-tryptophan ratio appears to be a promising biomarker of ADTKD progression and will require additional study.
Publicações recentes
Single-Molecule Real-Time Sequencing for MUC1 VNTR Variation to Improve Autosomal Dominant Tubulointerstitial Kidney Disease Diagnosis.
💬 OpiniãoA novel and two recurrent UMOD mutations in autosomal dominant tubulointerstitial kidney disease (ADTKD): a case series and literature review.
Lipocalin-2 Is Induced by Uromodulin Aggregates without Impacting Kidney Disease Progression in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD.
MANF Clears Mutant Uromodulin in Human Kidney Organoids of Autosomal Dominant Tubulointerstitial Kidney Disease.
De novo SEC61A1 mutation in congenital anemia and early-onset kidney disease: Case report and review of the literature.
📚 EuropePMC90 artigos no totalmostrando 168
MANF Clears Mutant Uromodulin in Human Kidney Organoids of Autosomal Dominant Tubulointerstitial Kidney Disease.
bioRxiv : the preprint server for biologyDe novo SEC61A1 mutation in congenital anemia and early-onset kidney disease: Case report and review of the literature.
GeneA Partial UMOD Deletion Results in Altered Uromodulin Synthesis and Autosomal-Dominant Tubulointerstitial Kidney Disease-Uromodulin.
Kidney medicinePlasma Metabolites Associated with CKD Stage in Autosomal Dominant Tubulointerstitial Kidney Disease.
Kidney360Early-onset kidney failure in a girl with autosomal dominant tubulointerstitial kidney disease due to a de novo UMOD variant.
CEN case reportsHyperuricemia and elevated creatinine in a child with anemia.
The Turkish journal of pediatricsCalorie Restriction Leads to Degradation of Mutant Uromodulin and Ameliorates Inflammation and Fibrosis in UMOD -Related Kidney Disease.
Journal of the American Society of Nephrology : JASNJAG1 of all trades, master of CKD? The role of JAG1 in autosomal dominant tubulointerstitial kidney disease.
Kidney internationalMutations in UMOD Contribute to the Pathogenesis of ADTKD-UMOD by Influencing the Function of Complement Factor H.
Journal of cellular and molecular medicineCase Report: UMOD gene mutation and phenotypic overlap with REN in autosomal dominant tubulointerstitial kidney disease.
Frontiers in geneticsThe diagnostic value of uromodulin protein measurement in autosomal dominant tubulointerstitial kidney disease due to uromodulin mutation (ADTKD-UMOD): serum or urine?
BMC nephrologyEmerging Mechanistic Roles of STING Signaling in Kidney Diseases.
The American journal of pathologyRenaming Medullary Cystic Kidney Disease: A Review of Semantic Nomenclature.
CureusTargeted sequencing and iterative assembly of near-complete genomes.
Nature communicationsAn unusual presentation of UMOD-associated autosomal dominant tubulointerstitial kidney disease in a pediatric patient.
Pediatric nephrology (Berlin, Germany)Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) in Chinese Patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal AssociationMono-allelic pathogenic variants in JAG1 cause autosomal dominant tubulo-interstitial kidney disease (ADTKD-JAG1).
Kidney internationalAn Observational Study of SGLT2 Inhibitors and Their Use in Autosomal Dominant Tubulointerstitial Kidney Disease.
Research squareLong-Read Sequencing of the MUC1 VNTR: Genomic Variation, Mutational Landscape, and Its Impact on ADTKD Diagnosis and Progression.
bioRxiv : the preprint server for biologyAutosomal Dominant Tubulointerstitial Kidney Disease: A Review.
American journal of kidney diseases : the official journal of the National Kidney FoundationGenetic analysis of UMOD gene mutation in autosomal dominant tubulointerstitial kidney disease.
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciencesAutosomal dominant tubulointerstitial kidney disease-UMOD: a short review.
Orphanet journal of rare diseasesQuantifying clinical and genetic factors influencing rate and severity of autosomal dominant tubulointerstitial kidney disease progression.
Journal of pharmacokinetics and pharmacodynamicsInitial Suspicion of Autosomal Dominant Polycystic Kidney Disease Resulted in a Diagnosis of Autosomal Dominant Tubulointerstitial Kidney Disease Caused by a UMOD Mutation.
Internal medicine (Tokyo, Japan)Phenotypes and the Importance of Genetic Analysis in Adult Patients with Nephrolithiasis and/or Nephrocalcinosis: A Single-Center Experience.
GenesCharacterization of recurrent UMOD variants (p.C255Y y p.Q316P) in a Galician cohort: genotype-phenotype correlation and clinical implications.
NefrologiaClinical use of the VNtyper-Kestrel pipeline for MUC1 variant detection in autosomal-dominant tubulointerstitial kidney disease.
Clinical and experimental nephrologyThe spectrum of diseases, genetic landscape and new mutation sites of hereditary cystic kidney disease.
Clinical kidney journalProteomic analysis of urinary extracellular vesicles from patients with ADTKD-HNF1β identifies roles for cilia-related proteins and serpins.
American journal of physiology. Renal physiologyEndoplasmic reticulum stress as a driver and therapeutic target for kidney disease.
Nature reviews. NephrologyPhenotype and genotype of autosomal dominant tubulointerstitial kidney disease in a Japanese cohort.
Clinical and experimental nephrologyPhenotypic Heterogeneity of ADTKD-MUC1 Diagnosed Using VNtyper, a Novel Genetic Technique.
American journal of kidney diseases : the official journal of the National Kidney FoundationA Novel Heterozygous and Pathogenic Variant of the HNF1B Gene Associated with Autosomal Dominant Tubulointerstitial Kidney Disease with a Broad Spectrum of Extrarenal Phenotypes.
Internal medicine (Tokyo, Japan)Genetic Assessment of Living Kidney Transplant Donors: A Survey of Canadian Practices.
Canadian journal of kidney health and diseaseMUC1-associated autosomal dominant tubulointerstitial kidney disease: prevalence in kidney failure of undetermined aetiology and clinical insights from Danish families.
Clinical kidney journalCase Report: A potentially pathogenic new variant of the REN gene found in a family experiencing autosomal dominant tubulointerstitial kidney disease.
Frontiers in pediatricsEight-fold increased COVID-19 mortality in autosomal dominant tubulointerstitial kidney disease due to MUC1 mutations: an observational study.
BMC nephrologyDisrupted uromodulin trafficking is rescued by targeting TMED cargo receptors.
The Journal of clinical investigationSystematic Screening of Autosomal Dominant Tubulointerstitial Kidney Disease- MUC1 27dupC Pathogenic Variant through Exome Sequencing.
Journal of the American Society of Nephrology : JASNFamilial juvenile hyperuricemic nephropathy: Revisiting the SLC8A1 gene, in a family with a novel terminal gross deletion in the UMOD gene.
NefrologiaA Rare Case of Atypical Hemolytic Uremic Syndrome Presenting as Chronic Interstitial Nephritis.
CureusAdvances in uromodulin biology and potential clinical applications.
Nature reviews. NephrologyHypoaldosteronism due to a novel SEC61A1 variant successfully treated with fludrocortisone.
Clinical kidney journalA Novel Monoallelic ALG5 Variant Causing Late-Onset ADPKD and Tubulointerstitial Fibrosis.
Kidney international reportsAutosomal-dominant tubulointerstitial kidney disease with a novel UMOD mutation, overlapping with Sjogren's syndrome: a case report.
CEN case reportsGenetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study.
American journal of kidney diseases : the official journal of the National Kidney FoundationGenomic Testing in Patients with Kidney Failure of an Unknown Cause: A National Australian Study.
Clinical journal of the American Society of Nephrology : CJASNGenetic Diagnosis of Adult Hemodialysis Patients With Unknown Etiology.
Kidney international reportsFrom Rare Disorders of Kidney Tubules to Acute Renal Injury: Progress and Prospective.
Kidney diseases (Basel, Switzerland)Description of a New Simple and Cost-Effective Molecular Testing That Could Simplify MUC1 Variant Detection.
Kidney international reportsCase-inspired exploration of renin mutations in autosomal dominant tubulointerstitial kidney disease: not all paths lead to the endoplasmic reticulum.
Pediatric nephrology (Berlin, Germany)The Pathophysiology of Inherited Renal Cystic Diseases.
GenesAutosomal dominant ApoA4 mutations present as tubulointerstitial kidney disease with medullary amyloidosis.
Kidney internationalAutosomic Dominant Tubulo Interstitial Kidney Disease: Case Report of a New Variant of the UMOD Gene.
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologiaAllelic effects on uromodulin aggregates drive autosomal dominant tubulointerstitial kidney disease.
EMBO molecular medicineAtypical ADPKD Due to a DNAJB11 Pathogenic Variant: An Educational Case Report.
Canadian journal of kidney health and diseaseMANF stimulates autophagy and restores mitochondrial homeostasis to treat autosomal dominant tubulointerstitial kidney disease in mice.
Nature communicationsMaternal health and pregnancy outcomes in autosomal dominant tubulointerstitial kidney disease.
Obstetric medicineUMOD-related autosomal dominant tubulointerstitial kidney disease: an unfavourable novel mutation.
NefrologiaVNtyper enables accurate alignment-free genotyping of MUC1 coding VNTR using short-read sequencing data in autosomal dominant tubulointerstitial kidney disease.
iScienceDnajb11-Kidney Disease Develops from Reduced Polycystin-1 Dosage but not Unfolded Protein Response in Mice.
Journal of the American Society of Nephrology : JASNHypoxia controls expression of kidney-pathogenic MUC1 variants.
Life science allianceLeader peptide or pro-segment mutants of renin are misrouted to mitochondria in autosomal dominant tubulointerstitial kidney disease.
Disease models & mechanismsGenomics in the kidney clinic.
Clinical medicine (London, England)Cystic Diseases of the Kidneys: From Bench to Bedside.
Indian journal of nephrologyCorrigendum to "Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease"Kidney International Reports, Volume 7, Issue 4, April 2022, Pages 857-866.
Kidney international reportsNovel MUC1 variant identified by massively parallel sequencing explains interstitial kidney disease in a large Dutch family.
Kidney internationalMANF stimulates autophagy and restores mitochondrial homeostasis to treat toxic proteinopathy.
bioRxiv : the preprint server for biologyInfluence of glycoprotein MUC1 on trafficking of the Ca2+-selective ion channels, TRPV5 and TRPV6, and on in vivo calcium homeostasis.
The Journal of biological chemistryGenetic Susceptibility to Chronic Kidney Disease: Links, Risks and Management.
International journal of nephrology and renovascular diseaseADTKD-UMOD in a girl with a de novo mutation: A case report.
Frontiers in medicineUMOD and you! Explaining a rare disease diagnosis.
Journal of rare diseases (Berlin, Germany)Transcription factor HNF1β controls a transcriptional network regulating kidney cell structure and tight junction integrity.
American journal of physiology. Renal physiologyAutosomal Dominant Tubulointerstitial Kidney Disease: An Emerging Cause of Genetic CKD.
Kidney international reportsAltered Serum Uric Acid Levels in Kidney Disorders.
Life (Basel, Switzerland)Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Journal of clinical medicineHypertensive Emergency In UMOD-Related Autosomal Dominant Tubulointerstitial Kidney Disease.
The Brown journal of hospital medicineUMOD Mutations in Chronic Kidney Disease in Taiwan.
BiomedicinesFramework From a Multidisciplinary Approach for Transitioning Variants of Unknown Significance From Clinical Genetic Testing in Kidney Disease to a Definitive Classification.
Kidney international reportsAn intermediate-effect size variant in UMOD confers risk for chronic kidney disease.
Proceedings of the National Academy of Sciences of the United States of AmericaMonoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis.
American journal of human geneticsKidney Histology Findings in a Patient with Autosomal Dominant Tubulointerstitial Kidney Disease Subtype Hepatocyte Nuclear Factor 1β.
Internal medicine (Tokyo, Japan)Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases.
Kidney internationalDetecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease.
Kidney international reportsAlport syndrome and autosomal dominant tubulointerstitial kidney disease frequently underlie end-stage renal disease of unknown origin-a single-center analysis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal AssociationUpregulation of C/EBP Homologous Protein induced by ER Stress Mediates Epithelial to Myofibroblast Transformation in ADTKD-UMOD.
International journal of medical sciencesPhenylbutyrate rescues the transport defect of the Sec61α mutations V67G and T185A for renin.
Life science allianceAutosomal dominant tubulointerstitial kidney disease with a novel heterozygous missense mutation in the uromodulin gene: A case report.
World journal of clinical casesWhat is the cause of kidney dysfunction in a newborn with trisomy 21? Answers.
Pediatric nephrology (Berlin, Germany)Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal AssociationFamily History is Important to Identify Patients with Monogenic Causes of Adult-Onset Chronic Kidney Disease.
NephronThe causes and consequences of paediatric kidney disease on adult nephrology care.
Pediatric nephrology (Berlin, Germany)Ultrabright plasmonic fluor nanolabel-enabled detection of a urinary ER stress biomarker in autosomal dominant tubulointerstitial kidney disease.
American journal of physiology. Renal physiologyUltra-rare renal diseases diagnosed with whole-exome sequencing: Utility in diagnosis and management.
BMC medical genomicsPlasma Mucin-1 (CA15-3) Levels in Autosomal Dominant Tubulointerstitial Kidney Disease due to MUC1 Mutations.
American journal of nephrologyAutosomal dominant tubulointerstitial kidney disease: more than just HNF1β.
Pediatric nephrology (Berlin, Germany)Autosomal Dominant Tubulointerstitial Kidney Disease HNF1B With Maturity-Onset Diabetes of the Young: A Case Report With Kidney Biopsy.
Kidney medicineFamilial juvenile hyperuricemia in early childhood in a boy with a novel gene mutation.
CEN case reportsAutosomal dominant tubulointerstitial kidney disease genotype and phenotype correlation in a Chinese cohort.
Scientific reportsUromodulin: Roles in Health and Disease.
Annual review of physiologyClinical utility of genetic testing in early-onset kidney disease: seven genes are the main players.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal AssociationSignificance of kidney biopsy in autosomal dominant tubulointerstitial kidney disease-UMOD: is kidney biopsy truly nonspecific?
BMC nephrologyA Rare Kidney Disease To Cure Them All? Towards Mechanism-Based Therapies for Proteinopathies.
Trends in molecular medicineThe Varied Clinical Presentation of Autosomal Dominant Tubulointerstitial Kidney Disease Due to HNF1β Mutations.
Kidney international reportsVariable Expressivity of HNF1B Nephropathy, From Renal Cysts and Diabetes to Medullary Sponge Kidney Through Tubulo-interstitial Kidney Disease.
Kidney international reportsClinical and genetic spectra of kidney disease caused by REN mutations.
Kidney internationalBi-allelic pathogenic variations in DNAJB11 cause Ivemark II syndrome, a renal-hepatic-pancreatic dysplasia.
Kidney internationalA woman with a dual genetic diagnosis of autosomal dominant tubulointerstitial kidney disease and KBG syndrome.
CEN case reportsGenetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutations.
Kidney international reportsA novel likely pathogenic variant in the UMOD gene in a family with autosomal dominant tubulointerstitial kidney disease: a case report.
BMC nephrology[Patients with a kidney disease can benefit from a specific genetic diagnose].
Ugeskrift for laegerAutosomal dominant tubulointerstitial kidney disease: a new tool to guide genetic testing.
Kidney internationalA novel HNF1B mutation p.R177Q in autosomal dominant tubulointerstitial kidney disease and maturity-onset diabetes of the young type 5: A pedigree-based case report.
MedicineAn international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes.
Kidney internationalSMRT sequencing revealed to be an effective method for ADTKD-MUC1 diagnosis through follow-up analysis of a Chinese family.
Scientific reportsClinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1.
Kidney internationalHypomagnesemia is underestimated in children with HNF1B mutations.
Pediatric nephrology (Berlin, Germany)Exome Sequencing and Identification of Phenocopies in Patients With Clinically Presumed Hereditary Nephropathies.
American journal of kidney diseases : the official journal of the National Kidney FoundationAutosomal Dominant Tubulointerstitial Kidney Disease-Uromodulin Misclassified as Focal Segmental Glomerulosclerosis or Hereditary Glomerular Disease.
Kidney international reportsRole of transcription factor hepatocyte nuclear factor-1β in polycystic kidney disease.
Cellular signallingRenal transplant outcomes in patients with autosomal dominant tubulointerstitial kidney disease.
Clinical transplantationHomoplasmy of the Mitochondrial DNA Mutation m.616T>C Leads to Mitochondrial Tubulointerstitial Kidney Disease and Encephalopathia.
NephronQuality of life in patients with autosomal dominant tubulointerstitial kidney disease .
Clinical nephrologyA novel disease-causing mutation in the Renin gene in a Tunisian family with autosomal dominant tubulointerstitial kidney disease.
The international journal of biochemistry & cell biologyAutosomal dominant tubulointerstitial kidney disease (ADTKD) in Ireland.
Renal failureAutosomal dominant tubulointerstitial kidney disease.
Nature reviews. Disease primersAutosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutation: A Two-Case Report and Literature Review.
NephronAutosomal Dominant Tubulointerstitial Kidney Disease with Adult Onset due to a Novel Renin Mutation Mapping in the Mature Protein.
Scientific reportsDiscovery of a Novel Mutation in the REN Gene in Patient With Chronic Progressive Kidney Disease of Unknown Etiology Presenting With Acute Spontaneous Carotid Artery Dissection.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke AssociationOutcomes of patient self-referral for the diagnosis of several rare inherited kidney diseases.
Genetics in medicine : official journal of the American College of Medical GeneticsDiagnosis and Long-term Management of Uromodulin Kidney Disease.
CureusUMOD gene mutations in Chinese patients with autosomal dominant tubulointerstitial kidney disease: a pediatric case report and literature review.
BMC pediatricsUromodulin-related autosomal-dominant tubulointerstitial kidney disease-pathogenetic insights based on a case.
Clinical kidney journalAutosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease.
BMC nephrologyMucin-1 Gene Mutation and the Kidney: The Link between Autosomal Dominant Tubulointerstitial Kidney Disease and Focal and Segmental Glomerulosclerosis.
Case reports in nephrologyEndoplasmic reticulum stress and monogenic kidney diseases in precision nephrology.
Pediatric nephrology (Berlin, Germany)Mechanism of Fibrosis in HNF1B-Related Autosomal Dominant Tubulointerstitial Kidney Disease.
Journal of the American Society of Nephrology : JASNBiallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease Recognition.
Journal of the American Society of Nephrology : JASNNoninvasive Immunohistochemical Diagnosis and Novel MUC1 Mutations Causing Autosomal Dominant Tubulointerstitial Kidney Disease.
Journal of the American Society of Nephrology : JASNAutosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1.
American journal of kidney diseases : the official journal of the National Kidney FoundationA novel uromodulin mutation in autosomal dominant tubulointerstitial kidney disease: a pedigree-based study and literature review.
Renal failureTranscription factor HNF1β regulates expression of the calcium-sensing receptor in the thick ascending limb of the kidney.
American journal of physiology. Renal physiologySingle molecule real time sequencing in ADTKD-MUC1 allows complete assembly of the VNTR and exact positioning of causative mutations.
Scientific reportsIdentification of a novel UMOD mutation (c.163G>A) in a Brazilian family with autosomal dominant tubulointerstitial kidney disease.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicasAutosomal Tubulointerstitial Kidney Disease-MUC1 Type: Differential Proteomics Suggests that Mutated MUC1 (insC) Affects Vesicular Transport in Renal Epithelial Cells.
ProteomicsA novel UMOD gene mutation associated with chronic kidney failure at a young age.
Clinical nephrologyAutosomal Dominant Tubulointerstitial Kidney Disease Due to MUC1 Mutation.
American journal of kidney diseases : the official journal of the National Kidney FoundationElevated urinary CRELD2 is associated with endoplasmic reticulum stress-mediated kidney disease.
JCI insightThe UMOD Locus: Insights into the Pathogenesis and Prognosis of Kidney Disease.
Journal of the American Society of Nephrology : JASNAnalysis of an ADTKD family with a novel frameshift mutation in MUC1 reveals characteristic features of mutant MUC1 protein.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal AssociationEarly involvement of cellular stress and inflammatory signals in the pathogenesis of tubulointerstitial kidney disease due to UMOD mutations.
Scientific reportsUromodulin: from physiology to rare and complex kidney disorders.
Nature reviews. NephrologyDiscovery of a novel dominant mutation in the REN gene after forty years of renal disease: a case report.
BMC nephrologyA review on autosomal dominant tubulointerstitial kidney disease.
Nefrologia : publicacion oficial de la Sociedad Espanola NefrologiaA novel homozygous UMOD mutation reveals gene dosage effects on uromodulin processing and urinary excretion.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal AssociationLoss of transcriptional activation of the potassium channel Kir5.1 by HNF1β drives autosomal dominant tubulointerstitial kidney disease.
Kidney internationalMutant uromodulin expression leads to altered homeostasis of the endoplasmic reticulum and activates the unfolded protein response.
PloS oneA mouse model for inherited renal fibrosis associated with endoplasmic reticulum stress.
Disease models & mechanismsMitochondrial Dysregulation Secondary to Endoplasmic Reticulum Stress in Autosomal Dominant Tubulointerstitial Kidney Disease - UMOD (ADTKD-UMOD).
Scientific reportsMucin-1 Increases Renal TRPV5 Activity In Vitro, and Urinary Level Associates with Calcium Nephrolithiasis in Patients.
Journal of the American Society of Nephrology : JASNA new missense mutation in UMOD gene leads to severely reduced serum uromodulin concentrations - A tool for the diagnosis of uromodulin-associated kidney disease.
Clinical biochemistryDevelopment and characterization of a pseudo multiple reaction monitoring method for the quantification of human uromodulin in urine.
BioanalysisDevelopment and Validation of a Mass Spectrometry-Based Assay for the Molecular Diagnosis of Mucin-1 Kidney Disease.
The Journal of molecular diagnostics : JMDTesting for the cytosine insertion in the VNTR of the MUC1 gene in a cohort of Italian patients with autosomal dominant tubulointerstitial kidney disease.
Journal of nephrologyFrom juvenile hyperuricaemia to dysfunctional uromodulin: an ongoing metamorphosis.
Pediatric nephrology (Berlin, Germany)Autosomal dominant tubulointerstitial kidney disease caused by uromodulin mutations: seek and you will find.
Wiener klinische WochenschriftHypomagnesemia as First Clinical Manifestation of ADTKD-HNF1B: A Case Series and Literature Review.
American journal of nephrologyAutosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.
Kidney internationalAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Doença renal túbulo-intersticial autossômica dominante.
É de uma associação que acompanha esta doença? Fale com a gente →
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Doença renal túbulo-intersticial autossômica dominante
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- Mutations in UMOD Contribute to the Pathogenesis of ADTKD-UMOD by Influencing the Function of Complement Factor H.
- MANF Clears Mutant Uromodulin in Human Kidney Organoids of Autosomal Dominant Tubulointerstitial Kidney Disease.
- De novo SEC61A1 mutation in congenital anemia and early-onset kidney disease: Case report and review of the literature.
- A Partial UMOD Deletion Results in Altered Uromodulin Synthesis and Autosomal-Dominant Tubulointerstitial Kidney Disease-Uromodulin.
- Plasma Metabolites Associated with CKD Stage in Autosomal Dominant Tubulointerstitial Kidney Disease.
- Single-Molecule Real-Time Sequencing for MUC1 VNTR Variation to Improve Autosomal Dominant Tubulointerstitial Kidney Disease Diagnosis.
- A novel and two recurrent UMOD mutations in autosomal dominant tubulointerstitial kidney disease (ADTKD): a case series and literature review.
- Lipocalin-2 Is Induced by Uromodulin Aggregates without Impacting Kidney Disease Progression in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:34149(Orphanet)
- MONDO:0008264(MONDO)
- GARD:10801(GARD (NIH))
- Variantes catalogadas(ClinVar)
- Busca completa no PubMed(PubMed)
- Q1916694(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
